aap to Discontinue Portions of Standard Trauma Business

To reduce costs and support development of other platform technologies, aap Implantate will discontinue parts of its standard trauma portfolio by the end of 2019.  Of note, the decision was made against the background of the significantly increased regulatory requirements of the new EU Medical Device Regulation (MDR). The partial...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us